The World Health Organization (WHO) plays a pivotal role in supporting countries in strengthening their regulatory systems, and promoting equitable access to quality, safe, productive, and affordable medical and health products.
WHO is mandated by Resolution WHA 67.20, to support countries in strengthening regulatory systems by:
- building regulatory capacity in Member States consistent with good regulatory practices, and
- promoting regulatory cooperation, convergence and transparency through networking, work-sharing, and reliance.
A team from WHO is currently conducting a thorough review of the regulatory system, including an assessment of the implementation status of the IDPs, an assessment of laboratory testing functions and a provision of technical support to guide the Bhutan Food and Drug Authority (BFDA) in realization of maturity level 02 and then subsequently level 03.